研究论文开放获取

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

Ana Oaknin, Kathleen N. Moore, Tim Meyer, José López-Picazo González, Lot A. Devriese, Asim Amin, Christopher D. Lao, Valentina Boni 等 20 位

Vall d'Hebron Hospital Universitari　Vall d'Hebron Institute of Oncology　Sarah Cannon　Oklahoma State University Oklahoma City

来源The Lancet Oncology

年份2024

DOI10.1016/s1470-2045(24)00088-3

原文https://doi.org/10.1016/s1470-2045(24)00088-3

阅读操作

确认中

在文库中上传 PDF 后可生成中文音频讲解。

摘要与影响

摘要 · 节选

暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。

逐年被引趋势

26130

2625

关键指标

被引次数 · OpenAlex

11.42

领域内被引倍数
同类平均 = 1

前 0.8%

引用位次
同领域 · 同年份 · 同类型

参考文献

Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。

AI 辅助阅读

依据：文献信息

论文问答

当前基于文献信息回答

可就本文提问；依据不足时会说明。

学术脉络

学科主题

生物医学

Cancer Immunotherapy and Biomarkers

Endometrial and Cervical Cancer Treatments · Immunotherapy and Immune Responses

参考文献 24

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

Thérèse Phillips, Pauline Simmons, H. David Inzunza · Applied immunohistochemistry & molecular morphology · 2015

被引 193

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos · The Journal of Pathology · 1999

被引 9,066

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari, Michael W. Sill, Harry J. Long · New England Journal of Medicine · 2014

被引 1,513

此处列出前 3 条

引用本文 64

Treatment advances across the cervical cancer spectrum

Alex Francoeur, Bradley J. Monk, Krishnansu S. Tewari · Nature Reviews Clinical Oncology · 2025

被引 112

Current trends in sensitizing immune checkpoint inhibitors for cancer treatment

Jing Wei, Wenke Li, Pengfei Zhang · Molecular Cancer · 2024

被引 110

Cervical Cancer

Krishnansu S. Tewari · New England Journal of Medicine · 2025

被引 96

按被引量排序，此处列出前 3 条